AZTD - ETF AI Analysis
Top Page
Aztlan Global Stock Selection DM SMID ETF (AZTD)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, suggesting its stock selection has recently worked well for investors.
Broad Global Diversification
Holdings spread across the U.S., Japan, and several European and other developed markets help reduce reliance on any single country’s economy.
Multiple Sector Exposure
Investments across consumer, financial, technology, health care, industrials, and other sectors help smooth out the impact if one industry hits a rough patch.
Negative Factors
Relatively High Expense Ratio
The fund’s fee is on the higher side for an ETF, which means more of the returns are used to cover costs instead of staying in investors’ pockets.
Mixed Performance Among Top Holdings
While several leading positions have shown strong gains, a few have been weak, which can create more uneven overall performance.
Small Fund Size
With a relatively modest amount of assets under management, the ETF may be more vulnerable to large investor inflows or outflows affecting trading and stability.
AZTD vs. SPDR S&P 500 ETF (SPY)
AUM36.71M
RegionDeveloped Markets
Expense Ratio0.75%
Beta0.97
IssuerAztlan
Inception DateAug 17, 2022
Dividend Yield0.98%
Asset ClassEquity
Index TrackedSolactive Aztlan Global Developed Markets SMID Cap Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume679
30 Day Avg. Volume1,862
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.38Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AZTD Summary
AZTD is an exchange-traded fund that follows the Solactive Aztlan Global Developed Markets SMID Cap Index, focusing on small and mid-sized companies in developed countries. It spreads investments across many sectors like consumer, financial, and technology, with over half in the U.S. and the rest in places like Japan and Europe. Well-known holdings include DaVita and Medpace Holdings. Someone might invest in AZTD for growth potential and diversification beyond the usual large U.S. stocks. A key risk is that smaller companies can be more volatile, so the share price can move up and down more than the overall market.
How much will it cost me?The Aztlan Global Stock Selection DM SMID ETF (AZTD) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the ETF is actively managed, focusing on small to mid-cap stocks in developed markets to capture unique growth opportunities. Active management typically involves higher costs due to the research and strategy required.
What would affect this ETF?The AZTD ETF, focusing on small to mid-sized companies in developed markets, could benefit from economic growth and innovation in sectors like technology and industrials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns in developed markets that could impact consumer cyclical and financial sectors. Regulatory changes or geopolitical tensions in key regions could also influence the performance of its top holdings.
AZTD Top 10 Holdings
AZTD leans into a global mix of small and mid-cap innovators, with tech and consumer names setting the tone. Lumentum and Arrow Electronics are rising, giving the fund a helpful push from the semiconductor and electronics side, while Halozyme and Exelixis add steady strength from health care. Japanese software player Cybozu has been more mixed, occasionally losing steam, and DocuSign’s recent wobble has slightly dragged on performance. Overall, the ETF is diversified across developed markets, but with a clear tilt toward nimble tech and growth-focused businesses.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Happinet Corporation | 3.47% | $1.27M | ¥239.05B | 52.54% | 73 Outperform | |
| Halozyme | 2.85% | $1.04M | $12.53B | 47.32% | 73 Outperform | |
| DocuSign | 2.78% | $1.02M | $12.55B | -2.64% | 71 Outperform | |
| Lumentum Holdings | 2.67% | $975.44K | $87.12B | 472.17% | 61 Neutral | |
| Cybozu, Inc. | 2.63% | $962.65K | ¥136.12B | -6.21% | 72 Outperform | |
| Koninklijke Bam Groep NV | 2.45% | $896.74K | €3.45B | 56.25% | 74 Outperform | |
| ― | 2.31% | $844.95K | ― | ― | ― | |
| Arrow Electronics | 2.27% | $830.21K | $11.56B | 86.54% | 64 Neutral | |
| Exelixis | 2.22% | $810.89K | $14.47B | 41.77% | 78 Outperform | |
| Lottomatica Group S.P.A. | 2.21% | $807.32K | €5.92B | 15.42% | 63 Neutral |
AZTD Technical Analysis
Negative
―
Price Trends
31.94
Negative
32.16
Negative
31.06
Negative
Market Momentum
-0.46
Positive
34.28
Neutral
22.35
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AZTD, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 31.09, equal to the 50-day MA of 31.94, and equal to the 200-day MA of 31.06, indicating a bearish trend. The MACD of -0.46 indicates Positive momentum. The RSI at 34.28 is Neutral, neither overbought nor oversold. The STOCH value of 22.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AZTD.
AZTD Peer Comparison
Comparison Results
Performance Comparison
AZTD
Aztlan Global Stock Selection DM SMID ETF
30.52
2.43
8.65%
KNO
AXS Knowledge Leaders ETF
―
―
―
TNXT
T. Rowe Price Innovation Leaders ETF
―
―
―
HDMV
First Trust Horizon Managed Volatility Developed Intl ETF
―
―
―
GLBL
Pacer MSCI World Industry Advantage ETF
―
―
―
WDAI
Pacer S&P World 3AI Top 300 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents